Tarsus Pharmaceuticals, Inc. (TARS)
67.13
-1.11
(-1.63%)
USD |
NASDAQ |
Mar 19, 10:13
Tarsus Pharmaceuticals EPS Diluted (Quarterly) : -0.1957 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Mirum Pharmaceuticals, Inc. | -0.111 |
| Summit Therapeutics, Inc. | -0.286 |
| Stoke Therapeutics, Inc. | -0.9922 |
| Vir Biotechnology, Inc. | -0.3083 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.373M |
| Revenue (Quarterly) | 151.67M |
| Total Expenses (Quarterly) | 160.04M |
| Enterprise Value | 2.569B |
| Gross Profit Margin (Quarterly) | 92.80% |
| Profit Margin (Quarterly) | -5.52% |
| Earnings Yield | -2.40% |
| Normalized Earnings Yield | -2.398 |